Bionano Genomics, Inc. (BNGO)
1.215
+0.02
(+1.25%)
USD |
NASDAQ |
Sep 09, 11:40
Bionano Genomics Total Liabilities (Quarterly) : 15.98M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.98M |
| March 31, 2026 | 27.34M |
| December 31, 2025 | 29.16M |
| September 30, 2025 | 29.26M |
| June 30, 2025 | 30.64M |
| March 31, 2025 | 30.23M |
| December 31, 2024 | 41.30M |
| September 30, 2024 | 38.49M |
| June 30, 2024 | 49.03M |
| March 31, 2024 | 75.22M |
| December 31, 2023 | 118.25M |
| September 30, 2023 | 62.90M |
| June 30, 2023 | 56.62M |
| March 31, 2023 | 60.66M |
| December 31, 2022 | 58.10M |
| September 30, 2022 | 41.96M |
| June 30, 2022 | 36.82M |
| Date | Value |
|---|---|
| March 31, 2022 | 37.03M |
| December 31, 2021 | 39.98M |
| September 30, 2021 | 18.09M |
| June 30, 2021 | 10.94M |
| March 31, 2021 | 22.14M |
| December 31, 2020 | 25.37M |
| September 30, 2020 | 26.72M |
| June 30, 2020 | 21.37M |
| March 31, 2020 | 23.32M |
| December 31, 2019 | 26.59M |
| September 30, 2019 | 26.59M |
| June 30, 2019 | 26.56M |
| March 31, 2019 | 23.68M |
| December 31, 2018 | 14.67M |
| September 30, 2018 | 15.43M |
| June 30, 2018 | 32.36M |
| March 31, 2018 | 27.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Harvard Bioscience, Inc. | 68.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.59M |
| Shareholders Equity (Quarterly) | 31.61M |
| Debt to Equity Ratio | 0.2121 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 17.60% |